natgillin/translations-raw huggingface dataset:
After single or multiple-dose oral administration of fesoterodine in doses from 4 mg to 28 mg, plasma concentrations of the active metabolite are proportional to the dose.
Pri peroralni uporabi posameznih ali večkratnih odmerkov fesoterodina v odmerkih od 4 do 28 mg so koncentracije aktivnega presnovka v plazmi sorazmerne z odmerkom.
After single oral administration of ceritinib in patients, plasma exposure to ceritinib, as represented by Cmax and AUClast, increased dose-proportionally over the 50 to 750 mg dose range.
Po peroralnem odmerjanju enkratnega odmerka ceritiniba bolnikom se je izpostavljenost ceritinibu v plazmi, ki jo predstavljata Cmax in AUClast, povečevala sorazmerno z odmerkom v razponu odmerkov od 50 mg do 750 mg.
After single oral doses using buffered solution mean maximum palonosetron concentrations (Cmax) and area under the concentration-time curve (AUC0-∞) were dose proportional over the dose range of 3.0 to 80 µg/kg in healthy subjects.
Po enkratnih peroralnih odmerkih z uporabo raztopine z uravnavanim pH so bile srednje najvišje koncentracije palonosterona (Cmax) in površina pod krivuljo koncentracija-čas (AUC0-∞) pri zdravih osebah sorazmerne odmerku v mejah odmerkov med 3,0 in 80 µg/kg.
After six months of treatment with 9.5 mg/24 hours, the doctor may increase the dose to 13.3 mg/24 hours if the patient’s condition has worsened.
Po šestih mesecih zdravljenja z obližem, ki vsebuje odmerek 9,5 mg/24 ur, lahko zdravnik odmerke poviša na 13,3 mg/24 ur, če se bolnikovo stanje poslabša.
After six months of treatment, 45% of patients taking RoActemra in combination with methotrexate (130 out of 290) and 39% of patients taking RoActemra on its own (113 out of 292) achieved remission (did not show symptoms of the disease), compared with 15% of those taking placebo plus methotrexate (43 out of 287).
Po šestmesečnem zdravljenju se je pri 45 % (130 od 290) bolnikov, ki so jemali zdravilo RoActemra v kombinaciji z metotreksatom in 39 % (113 od 292) bolnikov, ki so jemali samo zdravilo RoActemra, pojavila remisija v primerjavi s 15 % (43 od 287) tistih, ki so jemali placebo z metotreksatom.
After stabilisation of patient’s blood glucose adjustment of the dose should be considered (see sections 4.8 and 4.9).
Po ureditvi bolnikove glukoze v krvi je treba razmisliti o prilagoditvi odmerka (glejte poglavji 4.8 in 4.9).
After stabilisation of the patient’s blood glucose, adjustment of the dose should be considered (see sections 4.2, 4.8 and 4.9).
Po ureditvi bolnikove glukoze v krvi je treba razmisliti o prilagoditvi odmerka (glejte poglavja 4.2, 4.8 in 4.9).
After stabilisation of the patient’s blood glucose, adjustment of the dose should be considered (see sections 4.8 and 4.9).
Po ureditvi bolnikove glukoze v krvi je treba razmisliti o prilagoditvi odmerka (glejte poglavji 4.8 in 4.9).
After stabilisation of the patient’s blood glucose, adjustment of the dose should be considered (see sections 4.8 and 4.9).
Po ureditvi bolnikove koncentracije glukoze v krvi je treba razmisliti o prilagoditvi odmerka (glejte poglavji 4.8 in 4.9).
After starting somatropin treatment some patients may need to start thyroid hormone replacement.
Po uvedbi zdravljenja s somatropinom potrebujejo nekateri bolniki nadomestno zdravljenje s ščitničnim hormonom.
After stopping Hepsera tell your doctor immediately about any new, unusual or worsening symptoms that you notice after stopping treatment.
Po prekinitvi jemanja zdravila Hepsera nemudoma povejte zdravniku, če po prenehanju zdravljenja opazite nove ali nenavadne simptome ali poslabšanje simptomov.
After stopping the treatment, few antibody positive patients were followed-up for antibody status; the percentage decreased to approximately 90% within 3 months and 30% at 6 months or beyond.
Po prenehanju zdravljenja je bilo nekaj pacientov s pozitivnimi protitelesi spremljanih glede izvida protiteles; koncetracija protiteles se je v 3 mesecih znižala za približno 90 % in v 6 mesecih za 30 % ali več.
After stopping this medicine you must allow 14 days before taking any of these medicines.
Po prenehanju jemanja tega zdravila je potrebno počakati 14 dni, preden začnete jemati katero izmed teh zdravil.
After stopping this medicine, you must allow 14 days before taking any of these medicines.
Po prenehanju jemanja tega zdravila je potrebno počakati 14 dni, preden začnete jemati katero izmed teh zdravil.
After stopping treatment with Kivexa for reasons of a suspected HSR, Kivexa or any other medicinal product containing abacavir (e.g.
Po prenehanju zdravljenja z zdravilom Kivexa iz razloga suma na HSR, se zdravila Kivexa ali katerega koli drugega zdravila, ki vsebuje abakavir ( npr.
After stopping treatment with Triumeq for reasons of a suspected HSR, Triumeq or any other medicinal product containing abacavir or dolutegravir must never be re-initiated.
Po ukinitvi zdravljenja z zdravilom Triumeq zaradi suma na preobčutljivostno reakcijo se zdravljenja z zdravilom Triumeq ali katerim koli drugim zdravilom, ki vsebuje abakavir ali dolutegravir, ne sme nikoli več ponovno uvesti.
After stopping treatment with Trizivir for reasons of a suspected HSR, Trizivir or any other medicinal product containing abacavir (e.g.
Po prenehanju zdravljenja z zdravilom Trizivir iz razloga suma na HSR, se zdravila Trizivir ali katerega koli drugega zdravila, ki vsebuje abakavir ( npr.
After stopping treatment with Ziagen for reasons of a suspected HSR, Ziagen or any other medicinal product containing abacavir (e.g.
Po prenehanju zdravljenja z zdravilom Ziagen iz razloga suma na HSR, se zdravila Ziagen ali katerega koli drugega zdravila, ki vsebuje abakavir ( npr.
After stopping treatment, risk may remain elevated for at least 10 years.
Po ukinitvi zdravljenja lahko to tveganje ostane zvečano vsaj 10 let.
After storage at room temperature, the product may not be returned to the refrigerator.
Po shranjevanju pri sobni temperaturi zdravila ne smete shraniti nazaj v hladilnik.
After stratification according to the number of positive lymph nodes (1-3, 4+), 1,491 patients were randomized to receive either docetaxel 75 mg/m2 administered 1-hour after doxorubicin 50 mg/m2 and cyclophosphamide 500 mg/m2 (TAC arm), or doxorubicin 50 mg/m2 followed by fluorouracil 500 mg/m2 and cyclosphosphamide 500 mg/m2 (FAC arm).
Po stratifikaciji glede na število pozitivnih bezgavk (1–3, 4 ali več) je bilo 1.491 bolnic randomiziranih na prejemanje docetaksela 75 mg/m2, apliciranega 1 uro po doksorubicinu 50 mg/m2 in ciklofosfamidu 500 mg/m2 (krak TAC), ali na prejemanje doksorubicina 50 mg/m2, ki sta mu sledila fluorouracil 500 mg/m2 in ciklofosfamid 500 mg/m2 (krak FAC).
After stratification according to the number of positive lymph nodes (1-3, 4+), 1491 patients were randomized to receive either docetaxel 75 mg/m2 administered 1-hour after doxorubicin 50 mg/m2 and cyclophosphamide 500 mg/m2 (TAC arm), or doxorubicin 50 mg/m2 followed by fluorouracil 500 mg/m2 and cyclosphosphamide 500 mg/m2 (FAC arm).
Po stratifikaciji glede na število pozitivnih bezgavk (1–3, 4 ali več) je bilo 1.491 bolnic randomiziranih na prejemanje docetaksela 75 mg/m2, apliciranega 1 uro po doksorubicinu 50 mg/m2 in ciklofosfamidu 500 mg/m2 (krak TAC), ali na prejemanje doksorubicina 50 mg/m2, ki sta mu sledila fluorouracil 500 mg/m2 in ciklofosfamid 500 mg/m2 (krak FAC).
After stratification according to the number of positive lymph nodes (1-3, 4+), 1491 patients were randomized to receive either docetaxel 75 mg/m2 administered 1-hour after doxorubicin 50 mg/m2 and cyclophosphamide 500 mg/m2 (TAC arm), or doxorubicin 50 mg/m2 followed by fluorouracil 500 mg/m2 and cyclosphosphamide 500 mg/m2 (FAC arm).
Po stratifikaciji glede na število pozitivnih bezgavk (1–3, 4 ali več) je bilo 1.491 bolnic randomiziranih na prejemanjedocetaksela 75 mg/m2, apliciranega 1 uro po doksorubicinu 50 mg/m2 in ciklofosfamidu 500 mg/m2 (krak TAC), ali na prejemanje doksorubicina 50 mg/m2, ki sta mu sledila fluorouracil 500 mg/m2 in ciklofosfamid 500 mg/m2 (krak FAC).
After subcutaneous administration of 3 to 15 μg/kg romiplostim, maximum romiplostim serum levels in ITP patients were obtained after 7-50 hours (median 14 hours).
Po subkutani uporabi od 3 do 15 µg/kg romiplostima je bila največja koncentracija romiplostima v serumu pri bolnikih z ITP dosežena po 7 do 50 urah (mediano po 14 urah).
After subcutaneous administration of desoxycortone pivalate at a dosage of 11 mg/kg bodyweight (five times the recommended dosage), the plasma half-life (mean ± standard deviation) is approximately 17 ± 7 days, with a maximum concentration (Cmax) of 13.2 ± 5 ng/ml, and time to maximum concentration (Tmax) of 10 ± 3.5 days.
Po subkutani aplikaciji dezoksikorton pivalat v odmerku 11 mg/kg telesne teže (petkratni priporočeni odmerek) je razpolovni čas v plazmi (povprečje ± standardni odklon) približno 17 ± 7 dni, z največjo koncentracijo (Cmax) 13,2 ± 5 ng/ml, in čas do največje koncentracije (Tmax) je 10 ± 3,5 dni.
After subcutaneous administration of efalizumab peak plasma concentrations are reached after 1- 2 days.
Po subkutani uporabi doseže efalizumab največjo plazemsko koncentracijo po 1-2 dneh.
After subcutaneous dosing, fondaparinux is completely and rapidly absorbed (absolute bioavailability 100%).
Po subkutani uporabi se fondaparinuks popolno in hitro absorbira (absolutna biološka uporabnost 100
After subcutaneous injection in diabetic patients, insulin glargine is rapidly metabolised at the carboxyl terminus of the Beta chain with formation of two active metabolites M1 (21A-Gly-insulin) and M2 (21A-Gly-des-30B-Thr-insulin).
Po subkutanem injiciranju bolnikom s sladkorno boleznijo se insulin glargin hitro presnovi na karboksilnem koncu verige beta; nastaneta aktivna presnovka M1 (21A-Gly-insulin) in M2 (21A-Gly- des-30B-Thr-insulin).
After subcutaneous injection of 6 mg lipegfilgrastim at three different sites (upper arm, abdomen and thigh) in healthy volunteers, the bioavailability (peak concentration and area under the curve [AUC]) was lower after subcutaneous injection in the thigh compared to subcutaneous injection in the abdomen and in the upper arm.
Po subkutanem injiciranju 6 mg lipegfilgrastima v tri različne predele (nadlaket, trebuh in stegno) zdravim prostovoljcem je bila biološka uporabnost (največja koncentracija in površina pod krivuljo [AUC, area under the curve]) manjša po subkutanem injiciranju v stegno v primerjavi s subkutanim injiciranjem v trebuh ali nadlaket.
After subcutaneous injection of insulin glargine, insulin glargine is rapidly metabolized at the carboxyl terminus of the Beta chain with formation of two active metabolites M1 (21A-Gly-insulin) and M2 (21A-Gly-des-30B-Thr-insulin).
Po subkutanem injiciranju insulina glargina se ta hitro presnovi na karboksilnem koncu verige beta; nastaneta aktivna presnovka M1 (21A-Gly-insulin) in M2 (21A-Gly-des-30B-Thr-insulin).
After subcutaneous injection of Toujeo, the intra-subject variability, defined as the coefficient of variation for the insulin exposure during 24 hours was low at steady state (17.4%).
Po subkutanem injiciranju zdravila Toujeo je bila intraindividualna variabilnost, izražena s koeficientom variacije izpostavljenosti insulinu v teku 24 ur, v stanju dinamičnega ravnovesja majhna (17,4 %).
After subcutaneous injection, soluble and stable multi-hexamers of insulin degludec are formed creating a depot of insulin in the subcutaneous tissue, while not interfering with the rapid release of insulin aspart monomers into the circulation.
Po subkutani injekciji se tvorijo topni in stabilni multiheksameri insulina degludek in s tem ustvarijo depo insulina v podkožnem tkivu, hkrati pa ne ovirajo hitrega sproščanja monomerov insulina aspart v obtok.
After suitable training, your doctor may also allow you to inject Cimzia yourself.
Če ste bili za to ustrezno usposobljeni, vam lahko zdravnik dovoli, da si zdravilo injicirate sami.
After surgery in cats, once daily treatment may be continued at the same dosage and at the same time every day for up to 2 days.
Po operativnem posegu pri mačkah lahko še dva dni nadaljujete zdravljenje z enim odmerkom zdravila na dan, uporabite enak odmerek vsak dan ob istem času.
After surgery in cats, once daily treatment may be continued at the same dosage and at the same time every day for up to 2 days. .
Po operativnem posegu se pri mačkah lahko zdravljenje z dajanjem enakega odmerka dnevno ob istem času nadaljuje do največ dva dni.
After surgery in cats, once daily treatment may be continued for up to two further days.
Po operativnem posegu se pri mačkah lahko zdravljenje nadaljuje do največ dva dni z dajanjem enega odmerka dnevno.
After suspension, the delivered dose is 2 mg/0.65 ml.
Po suspendiranju je prejeti odmerek 2 mg/0,65 ml
After suspension, the mixture should only be used if it is white to off white and cloudy.
Po pripravi se lahko mešanico uporabi le, če je bela do belkasta in motna.
After swallowing your ADROVANCE tablet, wait at least 30 minutes before taking your first food, drink, or other medicine of the day, including antacids, calcium supplements and vitamins.
Ko pogoltnete tableto ADROVANCE, vsaj še 30 minut počakajte, preden zaužijete prvo hrano, pijačo ali katero koli drugo zdravilo, vključno z antacidi, dodatki kalcija in vitamini.
After swallowing your FOSAVANCE tablet, wait at least 30 minutes before taking your first food, drink, or other medicine of the day, including antacids, calcium supplements and vitamins.
Ko pogoltnete tableto FOSAVANCE, vsaj še 30 minut počakajte, preden zaužijete prvo hrano, pijačo ali katero koli drugo zdravilo, vključno z antacidi, dodatki kalcija in vitamini.
After swallowing your VANTAVO tablet, wait at least 30 minutes before taking your first food, drink, or other medicine of the day, including antacids, calcium supplements and vitamins.
Ko pogoltnete tableto VANTAVO, vsaj še 30 minut počakajte, preden zaužijete prvo hrano, pijačo ali katero koli drugo zdravilo, vključno z antacidi, dodatki kalcija in vitamini.
After switching from 3-day treatment of once daily 40 mg enoxaparin s.c., 24 hours after the last dose of enoxaparin the exposure to dabigatran was slightly lower than that after administration of dabigatran etexilate (single dose of 220 mg) alone.
Po prehodu s 3-dnevnega zdravljanja z enim odmerkom enoksaparina po 40 mg sc. na dan, je bila 24 ur po zadnjem odmerku enoksaparina izpostavljenost dabigatranu nekoliko manjša kot po dajanju samega dabigatran eteksilata (enkratnega odmerka po 220 mg).
After switching to MIRAPEXIN prolonged-release tablets, the dose may be adjusted depending on the patient’s therapeutic response (see section 5.1).
Po prehodu na MIRAPEXIN tablete s podaljšanim sproščanjem lahko njihov odmerek prilagodimo odzivanju na zdravljenje (glejte poglavje 5.1).
After switching to Oprymea prolonged-release tablets, the dose may be adjusted depending on the patient’s therapeutic response (see section 5.1).
Po prehodu na Oprymea tablete s podaljšanim sproščanjem lahko njihov odmerek prilagodimo bolnikovemu odzivanju na zdravljenje (glejte poglavje 5.1).
After switching to SIFROL prolonged-release tablets, the dose may be adjusted depending on the patient’s therapeutic response (see section 5.1).
Po prehodu na SIFROL tablete s podaljšanim sproščanjem lahko njihov odmerek prilagodimo odzivanju na zdravljenje (glejte poglavje 5.1).
After taking a pre-filled pen from the refrigerator, wait approximately 30 minutes to allow the Benepali solution in the pen to reach room temperature.
Ko napolnjeni injekcijski peresnik vzamete iz hladilnika, počakajte približno 30 minut, da se raztopina zdravila Benepali v peresniku segreje na sobno temperaturo.
After taking ellaOne, it is normal for your next period to be a few days late.
Po uporabi zdravila ellaOne je normalno, če naslednja menstruacija nastopi nekaj dni prepozno.
After taking ellaOne, some women experience dizziness, drowsiness, blurred vision and/or loss of concentration (see section 4 “Possible side effects”).
Po uporabi zdravila ellaOne se pri nekaterih ženskah pojavijo omotica, zaspanost, zamegljen vid in/ali poslabšanje koncentracije (glejte poglavje »Možni neželeni učinki«).
After taking one of them, wait at least 2 to 3 hours before taking the other
Kadar vzamete eno zdravilo, počakajte vsaj 2 do 3 ure, preden vzamete drugo;
After taking the capsule out, the cap should be returned on the bottle right away and the bottle should be tightly closed.
Takoj, ko vzamete kapsulo ven, vrnite zaporko na plastenko in jo tesno zaprite.
After taking your tablet, wait at least 30 minutes.
počakajte vsaj 30 minut, ko vzamete tableto.
After taking your tablet, wait at least 30 minutes.
počakajte vsaj 30 minut, ko vzamete tableto..
after taste, taste changed, abnormal sense of taste (i.e. metallic taste in mouth)
zaostali okus, sprememba okusa, nenormalen okus (tj. kovinski okus v ustih),
After that you will be provided with a maintenance pack containing grey pens with Plegridy 125 micrograms (for day 28 and then every two weeks).
Po tem boste prejeli vzdrževalno pakiranje, ki vsebuje sive injekcijske peresnike z zdravilom Plegridy 125 mikrogramov (za dan 28 in nato vsaka dva tedna).
After that you will be provided with a maintenance pack containing grey syringes with Plegridy 125 micrograms (for day 28 and then every two weeks).
Po tem boste prejeli vzdrževalno pakiranje, ki vsebuje sive injekcijske brizge z zdravilom Plegridy 125 mikrogramov (za dan 28 in nato vsaka dva tedna).
After that, the Genuair inhaler cannot be used again and you should start using a new Genuair inhaler.
Po tem inhalatorja Genuair ne morete več uporabljati, zato začnite uporabljati nov inhalator Genuair.
After that, the recommended dose is 1 injection of 2 ml injected once weekly.
Po tem je priporočeni odmerek 1 injekcija po 2 ml, injicirana enkrat na teden.
After that, the recommended dose is 2.2 milligrams per kilogram, up to 160 mg, once weekly on the same day of the week.
Temu sledi priporočeni odmerek 2,2 miligrama na kilogram, do 160 mg, enkrat na teden istega dne v tednu.
After that, the two groups switched to receiving the other medicine for a further 12 weeks.
Nato so preizkušanci v obeh skupinah za nadaljnjih 12 tednov prešli na drugo zdravilo.
After that, you will receive a monthly 80 mg injection.
Nato boste prejemali po eno miligramsko injekcijo na mesec.
After that, your doctor may increase the dosing frequency to one 0.26 mg prolonged-release tablet every day.
Nato bo lahko povečal pogostnost jemanja na eno tableto s podaljšanim sproščanjem po 0,26 mg na dan.
After that, your doctor may increase the dosing frequency to one 0.26 mg prolonged-release tablet every day.
Nato bo lahko povečal pogostnost jemanja na eno tableto s podaljšanim sproščanjem po 0,26 mg vsak dan.
After thawing
Po odmrznitvi
After thawing
Po odtajanju
After thawing, administer Imlygic as soon as practically feasible.
Po odtajanju zdravilo Imlygic uporabite čim prej, kot je to praktično mogoče.
After thawing, do not freeze again.
Po odmrznjenju ga ne smete ponovno zamrzovati.
After thawing, store unopened vials in the outer carton at 2-8°C for up to 30 days starting on:
Po odtalitvi shranjujte neodprte viale v zunanji škatli pri 2–8 °C do 30 dni po:
After thawing, the vaccine should be used immediately or can be stored at 2°C -8°C in the dark for up to 8 weeks prior to use.
Odmrznjeno cepivo je treba uporabiti takoj ali shraniti pri temperaturi med 2 °C in 8 °C v temnem prostoru do 8 tednov pred uporabo.
After thawing, the vaccine should be used immediately or can be stored at 2°C–8°C in the dark for up to 8 weeks prior to use.
Odmrznjeno cepivo je treba uporabiti takoj ali shraniti pri temperaturi med 2 °C in 8 °C v temnem prostoru do 8 tednov pred uporabo.
After thawing, unopened vials can be stored at 2-8°C and protected from light, for up to 30 days, without being frozen again during this period.
Po odtalitvi lahko neodprte viale shranjujete pri 2–8 °C in zaščitene pred svetlobo do 30 dni, vendar jih v tem času ne smete ponovno zamrzniti.
After thawing, unopened vials can be stored at 2-8C and protected from light, for up to 30 days, without being frozen again during this period.
Po odtalitvi lahko neodprte viale shranjujete pri 2–8 C in zaščitene pred svetlobo do 30 dni, vendar jih v tem času ne smete ponovno zamrzniti.
After the 15 minute wait, wash your hands and finish the rest of the steps right away.
Po 15 minutah čakanja si umijte roke in takoj opravite preostale korake.
After the 2 therapeutic sprays have been emitted, the patient will not hear a click and the counter will not advance beyond “2”; further sprays emitted will not be full sprays and should not be used therapeutically.
Po tistem, ko je iz steklenice oddal 2 terapevtska vpiha zdravila, bolnik ne sliši klika in število v okencu s števcem se ne zveča nad “2”; nadaljnji vpihi, oddani iz steklenice, ne bodo polni vpihi in jih bolnik ne sme uporabljati za zdravljenje.
After the 21 days, do not take any Cotellic tablets for 7 days.
Po 21 dneh naslednjih 7 dni ne vzemite nobene tablete zdravila Cotellic.
After the 24-month period, 61.3% of 62 patients included in the primary efficacy population did not experience a relapse based on CFS scores.
Po 24- mesečnem obdobju 61,3 % od 62 bolnikov, vključenih v primarno populacijo učinkovitosti, ni imelo recidiva na podlagi rezultatov CFS.
After the 3 mg/kg for 1.08 hours intravenous infusion, the median time (Tmax) ranged between 1.25 to 1.50 hours, and the mean (SD) Cmax ranged between 42694 (8443) and 46890 (6635) U/L over the studied cohorts.
Po intravenski infuziji 3 mg/kg v 1,08-ure intravenskem infundiranju je bil razpon medianega časa (Tmax) od 1,25 do 1,50 ure, povprečni (SD) Cmax pa je bil v proučevanih kohortah v območju med 42.694 (8.443) in 46.890 (6.635) e/l.
After the 30 minute wait, wash your hands and finish the rest of the steps right away.
Po 30 minutah čakanja si umijte roke in takoj opravite preostale korake.
After the 40 week non-treatment phase, a key secondary endpoint for both studies was the Continuous Abstinence Rate (CA) at week 52.
Po 40-tedenski fazi brez zdravila je bil sekundarni opazovani dogodek v obeh študijah delež trajne abstinence (CA – “continuous abstinence rate”) v 52. tednu.
After the 8 therapeutic sprays have been emitted, the patient will not hear a click and the counter will not advance beyond “8”; further sprays emitted will not be full sprays and should not be used therapeutically.
Po tistem, ko je iz steklenice oddal 8 terapevtskih vpihov zdravila, bolnik ne sliši klika in število v okencu s števcem se ne zveča nad “8”; nadaljnji vpihi, oddani iz steklenice, ne bodo polni vpihi in jih bolnik ne sme uporabljati za zdravljenje.
After the 8-week prophylaxis period, the incidences of flares increased and gradually decreased over time (64% and 70% of subjects received treatment for gout flares from Week 8-52).
Po 8-tednov preventivnega zdravljenja se je pojavnost večjega števila napadov protina zmanjšala in se postopoma zniževala (64 % in 70 % oseb je prejelo zdravljenje proti izbruhom protina v tednih od 8 do 52).
After the addition of the DTPw-HBV component to the HIB powder, the mixture should be well shaken until
Po dodajanju komponente DTPw-HBV komponenti HIB v obliki praška, je potrebno mešanico dobro pretresti, da se prašek popolnoma raztopi.
After the administration of an overdose (10 doses), transient moderate to marked hyperthermia, as well as local reactions (swelling, redness or slight pain, and in some cases, heat at the injection site) may occur.
Po dajanju prevelikega odmerka (10 odmerkov), se lahko pojavijo prehodno zmerno do močnejše povišana telesna temperatura, lahko pa tudi lokalne reakcije (oteklina, eritem ali rahla bolečina in v nekaterih primerih toplota na mestu injiciranja).
After the administration of crushed Xarelto15 mg or 20 mg film-coated tablets, the dose should then be immediately followed by enteral feeding (see section 5.2).
Po dajanju zdrobljene 15 mg ali 20 mg filmsko obložene tablete zdravila Xarelto mora odmerku nemudoma slediti enteralna prehrana (glejte poglavje 5.2).